HealthStream (NASDAQ:HSTM) Hits New 12-Month Low – What’s Next?

HealthStream, Inc. (NASDAQ:HSTM) reached a new 52-week low during trading on Tuesday . The company traded as low as $20.84 and last traded at $20.8950, with a volume of 193542 shares. The stock had previously closed at $21.93.

Wall Street Analyst Weigh In

Several equities analysts recently commented on HSTM shares. Canaccord Genuity Group set a $25.00 price objective on HealthStream in a research note on Thursday, January 8th. Weiss Ratings reissued a “hold (c)” rating on shares of HealthStream in a research report on Wednesday, October 8th. Citigroup reaffirmed a “market perform” rating on shares of HealthStream in a report on Tuesday, January 6th. Finally, Wall Street Zen lowered shares of HealthStream from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. One research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $25.00.

HealthStream Trading Down 4.7%

The stock’s fifty day moving average is $23.27 and its two-hundred day moving average is $25.54. The firm has a market cap of $620.10 million, a P/E ratio of 30.74, a price-to-earnings-growth ratio of 2.41 and a beta of 0.44.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings results on Monday, November 3rd. The technology company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.03. The firm had revenue of $76.47 million for the quarter, compared to analysts’ expectations of $75.52 million. HealthStream had a net margin of 6.93% and a return on equity of 5.82%. On average, analysts forecast that HealthStream, Inc. will post 0.63 EPS for the current year.

HealthStream declared that its Board of Directors has authorized a share repurchase program on Tuesday, November 11th that allows the company to repurchase $10.00 million in outstanding shares. This repurchase authorization allows the technology company to purchase up to 1.3% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

Insider Activity

In other HealthStream news, Director Tate Deborah Taylor sold 1,580 shares of HealthStream stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $25.46, for a total transaction of $40,226.80. Following the completion of the sale, the director directly owned 23,127 shares in the company, valued at $588,813.42. The trade was a 6.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Kevin P. O’hara sold 2,000 shares of the stock in a transaction on Monday, December 8th. The stock was sold at an average price of $24.26, for a total transaction of $48,520.00. Following the completion of the transaction, the executive vice president directly owned 16,373 shares in the company, valued at $397,208.98. The trade was a 10.89% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 5,680 shares of company stock worth $139,336. 20.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in HSTM. Geode Capital Management LLC lifted its stake in shares of HealthStream by 5.3% in the 2nd quarter. Geode Capital Management LLC now owns 766,193 shares of the technology company’s stock valued at $21,202,000 after acquiring an additional 38,868 shares during the last quarter. Assenagon Asset Management S.A. bought a new stake in HealthStream in the third quarter valued at approximately $1,264,000. Acadian Asset Management LLC boosted its stake in shares of HealthStream by 5.1% during the second quarter. Acadian Asset Management LLC now owns 762,343 shares of the technology company’s stock valued at $21,077,000 after purchasing an additional 37,004 shares during the period. Robeco Institutional Asset Management B.V. boosted its stake in shares of HealthStream by 162.1% during the second quarter. Robeco Institutional Asset Management B.V. now owns 380,604 shares of the technology company’s stock valued at $10,531,000 after purchasing an additional 235,382 shares during the period. Finally, Integrated Quantitative Investments LLC grew its holdings in shares of HealthStream by 13.4% in the second quarter. Integrated Quantitative Investments LLC now owns 41,426 shares of the technology company’s stock worth $1,146,000 after purchasing an additional 4,895 shares during the last quarter. 69.58% of the stock is owned by hedge funds and other institutional investors.

HealthStream Company Profile

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.